Directory of services
DIRECTORY OF SERVICES | |||||
Area of analysis: Evaluation of medical devices | |||||
Mode of analysis: hemocompatibility tests | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Evaluation of hemocompatibility of dialyzers, oxygenators, plasma filters and other medical devices according to DIN EN ISO 10993-4:2017 (sC5b-9, C3a, TAT, Cell count, Heparin, Hemolysis, NIH and others) | Medical devices, biomaterials | Ex vivo recirculation with heparinized human blood | AA-001, 17/02.2025 | Ismatec MCP, Ismatec MCP-Process | + |
Evaluation of hemocompatibility of flat sheet membranes and medical devices according to DIN EN ISO 10993-4:2017 in petri-dish-model | Medical devices, Flat sheets, Flat sheet membranes, Particles, biomaterials | Ex vivo incubation with heparinized human blood | AA-010, 10/02.2025 | Certomat U | + |
MAT – Monocyte activation test according to Ph. Eur. 2.6.30, Quantitative detection of pyrogens in human whole blood model by IL-1ß | Medical devices, biomaterials | Incubation with heparinized human blood | AA-012, 20/02.2025 AA-096, 02/02.2025 |
Certomat U | + |
Pyrogenretention (ex vivo) | Hemodialyzers, medical devices with hollow fiber membranes | Ex vivo Hemodialysis, Cytokine induction | AA-011, 05/05.2011 | Ismatec MCP, Ismatec MCP-Process | – |
Released: | |||||
Date: | |||||
Area of analysis: Microbiological-hygienic testing of medical devices | |||||
Mode of analysis: Quantitive determination of pyrogenic contaminants | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Determination of endotoxins/pyrogens by LAL-Assay accoring to Ph. Eur. 2.6.14 | Medical products, raw materials | Turbidimetry | AA-013, 05/02.2025 | BioTek ELx808 | + |
Area of analysis: Evaluation of medical devices | |||||
Mode of analysis: Quality testing | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Evaluation of redness | Hemodialyzer, medical devices with hollow fiber membranes | 1) Recirculation model with heparinized human blood; Image analysis 2) Clinical testing; Image analysis |
AA-067, 03/12.2017 | Minolta Chroma-Meter CR-310 | – |
Particle count | Hemodialyzer, medical devices, tubing sets | Particel count in rinsing solution | AA-079, 03/03.2017 | Ismatec MCP | – |
Gravity driven plasmaseparation | Loop module | Plasmaseparation | AA-087, 03/06.2016 | Test Rig, Plasmafilter | – |
Structural integrity according to DIN EN ISO 8637-1:2020 | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Pressure hold test | AA-094, 03/06.2025 | Pressure hold equipment, vacuum pump | + |
Integrity test of the blood compartment according to DIN EN ISO 8637-1:2020 | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Pressure hold test of the blood compartment | AA-104, 01/07.2023 | Pressure hold equipment, dialysis monitor | + |
Structural integrity test/Leak test and integrity of the blood compartment of plasmafilters according to ISO 8637-3 | Plasmafilters | Pressure hold test | AA-091, 05/06.2025 | Pressure hold equipment, vacuum pump | – |
Area of analysis: Evaluation of medical devices | |||||
Mode of analysis: Determination of performance parameters | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Low molecular weight solute clearance according to DIN EN ISO 8637-1:2020 (ex vivo) | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Ex vivo Hemodialysis | AA-039, 19/04.2024 | Dialysis monitor | + |
Blood clearance of middle molecules with albumin loss according to DIN EN ISO 8637-1:2020 | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Ex vivo Hemodialysis | AA-039, 19/04.2024 | Dialysis monitor | + |
Clearance according to japanese standard: Manual for Functional Classification of Dialyzers; Methods for performance evaluation of blood purifiers | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Ex vivo Hemodialysis | AA-100, 01/05.2020 | Dialysis monitor | + |
Determination of sieving coefficients according to DIN EN ISO 8637-1:2020 (ex vivo) | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Ex vivo Hemodialysis | AA-040, 11/04.2024 | Dialysis monitor | + |
Determination of pressure drop, Volume of blood compartment, transmembrane pressure TMP, ultrafiltration rate UFR and ultrafiltration coefficient KUF according to DIN EN ISO 8637-1:2020 | Hemodialyzers, hemodiafilter, hemofilter, hemoconcentrators | Hemodialysis; Recirculation model with heparinized human blood | AA-065, 10/04.2024 AA-042, 03/05.2013 |
Dialysis monitor | + |
Determination of performance parameters of plasmafilters (Sieving coefficients, filtration rate, hemolysis, TMP) according to ISO 8637-3 | Plasmafilter | ex vivo Recirculation model with heparinized human blood | AA-091, 06/06.2025 | Dialysis monitor | – |
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Isolation of proteins from hemofiltrate of patients with Kidney Failure (ex vivo) | Hemofiltrate | Ultrafiltration, Chromatography | AA-037, 07/08.2022 | Ismatec MCP, Ismatec MCP-Process | – |
Determination of performance parameters of plasmafractionation devices (Sieving Coefficients, ex vivo) | Plasmafractionation devices | ex vivo Plasmafractionation | AA-077, 05/03.2016 | Plasmafractionation monitor Infomed CF-100 | – |
Determination of O2 and CO2 transfer rates of oxygenators according to DIN EN ISO 7199:2020 | Oxygenators | ex vivo Recirculation model with heparinized human blood | AA-102, 01/02.2022 | Customer specified blood pump | + |
Retention and damage of blood cells/plasma components by transfusion sets according to DIN EN ISO 1135-4:2016 and 1135-5:2016 | Transfusion sets, pumps for transfusion | Filtration of different media (blood/plasma products) through the transfusion sets | AA-105, 01/01.2024 | Transfusion sets, pumps for transfusion | + |
Blood Cell Damage (BCD) according to DIN EN ISO 7199 | Oxygenators | ex vivo Recirculation model with heparinized human blood | AA-106, 01/06.2025 | Customer specified blood pump | – |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Spectrometry (UV-/ VIS-Photometry/ Nephelometry) | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
a-Amylase | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
α1-Antitrypsin | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
α1-acidic Glycoprotein | Heparinized plasma, Serum, Aqueous Solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
α1-Microglobulin | Heparinized plasma, Serum, Urine, Aqueous Solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
α2-Macroglobulin | Heparinized plasma, Serum, Urine, Aqueous Solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
ADNase B | Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Alanine aminotransferase | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Albumin | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Albumin | Citrated plasma, Serum, Aqueous Solutions* | Photometry (BCG method) | AA-103, 01/10.2022 | BioTek ELx808 | + |
Albumin | Heparinized and EDTA plasma, Serum, Urine, Aqueous Solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Alkaline phosphatase | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Ammonia | EDTA plasma | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Antistreptolysin (ASL) | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Antithrombin III | EDTA and citrated plasma | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Apolipoprotein A-I | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Apolipoprotein A-II | Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Apolipoprotein B | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Apolipoprotein E | Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Aspartate aminotransferase | Heparinized and EDTA plasma | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
ß2-Microglobulin | Heparinized plasma, Serum, Urine, Aqueous Solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
BCA, Protein determination | Heparinized, citrated and EDTA plasma, Serum, Aqueous Solutions* | Photometry | AA-074, 06/02.2025 | BioTek ELx808 | + |
Bicarbonate | Heparinized plasma | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Bilirubin Direct | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Bilirubin Total | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
C1-Inhibitor | EDTA and citrated plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Calcium | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Carbohydrate-Deficient Transferrin | Haparinzed and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Cholesterol | Haparinzed and EDTA plasma, Serum, Aqueous solutions* | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Coeruloplasmin | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
C-reactive Protein (CRP) | Haparinzed and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
C-reactive Protein (CRP) | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
C-reactive Protein (CRP) High Sensitive | Haparinzed and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Creatinine | Haparinzed and EDTA plasma, Serum, Urine, Aqueous solutions* | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Creatinine (Jaffé) | Haparinzed and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Creatine kinase | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Cystatin C | Heparinized and EDTA plasma, Serum, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
DEHP equivalents | Aqueous solutions | Photometry | AA-099, 01/07.2019 | Shimadzu UV-1650PC | – |
D-Dimer | Heparinized, EDTA and Citrated plasma | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Ferrum | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Factor VIII Coatest | Citrated plasma | Photometrie | AA-093, 02/07.2019 | BioTek ELx808 | + |
Ferritin | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Fibrinogen | EDTA and citrated plasma, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Fibronectin | EDTA and citrated plasma | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
free Hemoglobin in plasma (hemolysis) | Heparinized plasma, Serum | Photometry | AA-056, 13/02.2025 | Shimadzu UV-1650PC | + |
Glucose | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Hemopexin | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Haptoglobin | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
HbA1c | Heparinized and EDTA plasma | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
HDL Cholesterol | Heparinized and EDTA plasma, Serum, Aqueous solutions* | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Heparin | Citrated plasma | Photometry | AA-002, 16/06.2025 | BioTek ELx808 | + |
Homocysteine | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Free Immunoglubulin Light chains, Type kappa | Heparinized and EDTA plasma, Serum, Urine, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Free Immunoglubulin Light chains, Type lambda | Heparinized and EDTA plasma, Serum, Urine, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Immunoglobulin A (IgA) | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Immunoglobulin E (IgE) | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Immunoglobulin G (IgG) | Heparinized plasma, Serum, Urine, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Immunoglobulin G (IgG) Subclass 1 | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Immunoglobulin G (IgG) subclass 2 | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Immunoglobulin G (IgG) subclass 3 | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Immunoglobulin G (IgG) subclass 4 | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Immunoglobulin M (IgM) | Heparinized plasma, Serum, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Inulin | CPD, Citrated and Heparinized plasma, Aqueous solutions* | Photometry | AA-048, 10/04.2023 | Shimadzu UV-1650PC | + |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Iron | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Complement factor C3c | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Complement factor C4 | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Lactate | Heparinized plasma | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
LDH | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
LDL-Cholesterol | Heparinized plasma, Serum, Aqueous solutions* | Photometrie | AA-057, 10/07.2019 | Roche cobas c111 | + |
Lipase | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Lipoprotein (a) | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Magnesium | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Myoglobin | Heparinized and EDTA plasma, Serum, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Pancreatic a-Amylase | Heparinized plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Peroxide (PerOX) | EDTA plasma, Serum | Photometry | AA-019, 13/02.2025 | BioTek ELx808 | + |
Phosphate | Heparinized and EDTA plasma, Serum, Urine, Aqueous solutions* | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Plasminogen | EDTA and citrated plasma | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Pre albumin | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Retinol binding Protein (RBP) | Heparinized plasma, Serum, Aqueous solutions* | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | + |
Rheumatoid factor (RF) | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Serum Amyloid A Protein (SAA) | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Soluble Transferrin Receptor | Heparinized plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Total protein | Heparinized and EDTA plasma, Serum, Urine, Aqueous solutions* | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Transferrin | Heparinized and EDTA plasma, Serum | Nephelometry | AA-014, 12/07.2019 | Siemens BN ProSpec | – |
Triglyceride | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Urea | Heparinized and EDTA plasma, Serum, Urine, Aqueous solutions* | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | + |
Uric Acid | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
Vitamin B12 | Heparinized and EDTA plasma, Serum, Aqueous solutions* | Photometry | AA-047, 14/06.2025 | Shimadzu UV-1650PC | + |
γ‑Glutamyltransferase | Heparinized and EDTA plasma, Serum | Photometry | AA-057, 10/07.2019 | Roche cobas c111 | – |
* aqueous solution: in house validated; out of scope of D-PL-19275-01-00, within the scope of D-PL-19275-02-00 | |||||
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Flow cytometry | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Apoptose / Annexin V | Heparinized blood | Flow cytometry | AA-020, 05/07.2019 | BD FACSVerse | + |
Characterisation MSC | Cell culture | Flow cytometry | AA-095, 01/02.2016 | BD FACSVerse | – |
Oxidative Burst | Heparinized blood | Flow cytometry | AA-021, 14/02.2025 | BD FACSVerse | + |
Granulocyte Activation | EDTA blood | Flow cytometry | AA-075, 04/02.2025 | BD FACSVerse | + |
Monocyte Subpopulations | EDTA blood | Flow cytometry | AA-080, 07/03.2017 | BD FACSVerse | + |
BD Leucocount | Heparinized plasma | Flow cytometry | AA-083, 02/06.2015 | BD FACSVerse | + |
TBNK-Lymphocyte Subpopulations | EDTA blood | Flow cytometry | AA-084, 02/07.2014 | BD FACSVerse | + |
BD Plasma Count | Heparinized, Citrated and EDTA plasma | Flow cytometry | AA-085, 07/10.2017 | BD FACSVerse | + |
Dentritic cells | EDTA blood | Flow cytometry | AA-086, 03/06.2015 | BD FACSVerse | + |
Platelet activation PAC-1/CD62P | Citrated blood | Flow cytometry | AA-098, 08/02.2025 | BD FACSVerse | + |
Blood cells: Platelets, Erythrocytes, Leucocytes, Hematocrit, Hemoglobin etc. | Heparinized, Citrated and EDTA blood | Impedance method | AA-005, 13/02.2025 | ABX Pentra 60 C+ | + |
Cell Viability | Heparinized, Citrated and EDTA plasma, Cell culture | Flow cytometry | AA-092, 03/03.2017 | BD FACSVerse | – |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Ligand assays (ELISA) | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
HMW-Adiponectin | Heparinized and Citrated plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | – |
Total-Adiponectin | Heparinized and Citrated plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | – |
Apolipoprotein C3 | Heparinized and EDTA plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | – |
Bisphenol A (BPA) | Heparinized and Citrated plasma, Serum | ELSIA | AA-030, 05/06.2015 | BioTek ELx808 | + |
BNP | Plasma, Serum | ELISA | Instructions from the supplier | BioTek ELx808 | – |
Bradykinin | EDTA plasma | ELISA | AA-017, 07/05.2020 | BioTek ELx808 | + |
Fetuin A | Serum | ELISA | Instructions from the supplier | BioTek ELx808 | – |
FGF23 | EDTA plasma, cell culture medium | ELISA | Instructions from the supplier | BioTek ELx808 | – |
Interleukin 1-ß | Heparinized, Citrated and EDTA plasma, Serum | ELISA | AA-012, 20/02.2025 | BioTek ELx808 | + |
Interleukin 6 | Heparinized, Citrated and EDTA plasma, Serum | ELISA | AA-038, 09/02.2021 | BioTek ELx808 | + |
Complementaktivation: C3a, C5a, sC5b-9 | Citrated and EDTA plasma | ELISA | AA-004, 13/02.2025 | BioTek ELx808 | + |
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Leptin | Heparinized, Citrated and EDTA plasma, Serum | ELISA | AA-101, 01/05.2020 | BioTek ELx808 | – |
Myeloperoxidase (MPO) | EDTA plasma | ELISA | AA-024, 10/02.2025 | BioTek ELx808 | + |
ox LDL | Heparinized and EDTA plasma, Serum | ELISA | AA-036, 09/02.2025 | BioTek ELx808 | + |
Platelet factor 4 (PF4) | CTAD plasma | ELISA | AA-015, 16/02.2025 | BioTek ELx808 | + |
PMN Elastase | Citrated and EDTA plasma | ELISA | AA-022, 08/02.2025 | BioTek ELx808 | + |
Thrombin-Antithrombin III-Complex (TAT) | Citrated plasma | ELISA | AA-003, 13/02.2025 | BioTek ELx808 | + |
TNF-α | Heparinized, Citrated and EDTA plasma, Serum | ELISA | AA-029, 05/04.2023 | BioTek ELx808 | + |
Factor V | Citrated and EDTA plasma | ELISA | AA-069, 06/07.2019 | BioTek ELx808 | + |
Factor X | Citrated and EDTA plasma | ELISA | AA-070, 04/07.2019 | BioTek ELx808 | + |
Protein C | Citrated plasma | ELISA | AA-071, 04/06.2015 | BioTek ELx808 | – |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Chromatography | |||||
High Perfandmance Liquid Chromatography (HPLC) | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Indoxyl sulfate | Heparinized, Citrated and EDTA plasma, Serum | HPLC | AA-060, 09/02.2025 | Dionex Ultimate 3000 | + |
p-Cresyl sulfate | Heparinized, Citrated and EDTA plasma, Serum | HPLC | AA-060, 09/02.2025 | Dionex Ultimate 3000 | + |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Elektrophoresis | |||||
Elektrophandese (SDS-Gelektrophoresis) | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Relative molecular weight of proteins | Heparinized, Citrated and EDTA plasma, Serum | SDS-Gel electrophoresis | AA-051, 04/02.2025 | Electrophoresis equipment EPS 301 | + |
Proteins | Heparinized, Citrated and EDTA plasma, Serum | Gel electrophoresis (IEF / 2-D PAGE) | AA-073, 01/12.2013 | Electrophoresis equipment EPS 301 | + |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Electrochemical measurements | |||||
Potentiometry | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Na+ | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
K+ | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
Cl- | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
Ca2+ | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
pH | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
PO2 | Heparinized blood | Amperometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
PCO2 | Heparinized blood | Potentiometry | BA-014, 02/01.2024 BA-022, 01/06.2015 | Cobas b 123 OPTI CCA-TS | + |
Glucose | Heparinized blood | Amperometry | BA-014, 02/01.2024 | Cobas b 123 | + |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Fluorescence spektrometry | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Cytotoxicity ex vivo according to DIN EN ISO 10993-5 | Aqueous solutions, Extracts | Fluorimetry | AA-035, 07/07.2019 DIN EN ISO 10993-5, DIN EN ISO 10993-12 |
BioTek ELx808 | – |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Light microscopy | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Blood slides, Microscopic evaluation of blood slides, Erythrocytes | Blood slide | Microscopy | AA-097, 01/06.2016 | RAL Stainbox, HemaPrep, Leitz, Laborlux 12 | – |
Area of analysis: Biochemistry/Clinical chemistry | |||||
Mode of analysis: Coagulometry | |||||
Analyte (measured variable) | Sample material (Matrix) | Method | SOP/Standard | Equipment | Accredited |
Determination of ACT with GEM Hemochron 100 | Heparinized blood | Coagulometry | AA-108, 01/06.2025 | GEM Hemochron 100 | – |